Tech Rx Delivered: DEV IT Clinches Rs 4.4 Crore Order from Alivus Lifesciences to Power Pharma Digitization

Unknown Apr 02, 2026 650 Views

Dev Information Technology Ltd (DEV IT) has secured a Rs 4.4 crore order from Alivus Lifesciences, marking a strategic win in the pharmaceutical sector’s digital transformation journey. The engagement spans enterprise software deployment and advisory services, reinforcing DEV IT’s pos...

Key Highlights of the Engagement

Rs 3.60 crore allocated for Microsoft Select Plus perpetual licenses, with DEV IT playing a key advisory role in aligning Alivus’s IT infrastructure with the optimal licensing model
Rs 80 lakh direct order for a suite of enterprise software solutions, including products from Microsoft, Zoho, Adobe, and TeamViewer
The combined order reflects DEV IT’s ability to deliver integrated, multiproduct IT solutions tailored to sectorspecific needs

Strategic Value and Execution Strength

DEV IT’s advisory role in the licensing process showcases its expertise in navigating complex enterprise IT requirements
The company’s ability to bundle and deploy diverse software platforms positions it as a onestop solution provider for digital modernization
The deal strengthens DEV IT’s footprint in the pharmaceutical sector, a space increasingly reliant on scalable and secure IT infrastructure

Leadership Commentary and Team Recognition

Founder and Chairman Pranav Pandya emphasized that the milestone reflects client trust in DEV IT’s problemsolving capabilities
Key contributors to the deal include Yogesh, Julie, Sanjay, Himani, and Paritosh, with backend support from Jaimin and Vishal
The company also noted growing traction in the government sector, adding depth to its portfolio

Market Impact and Forward Outlook

DEV IT’s stock rose over 2 percent following the announcement, signaling positive investor sentiment
The company continues to focus on scalable, customercentric solutions across cloud services, enterprise applications, and managed IT services
Proprietary platforms like Talligence (analytics) and ByteSigner (digital signing) are expected to complement future enterprise deployments

As DEV IT deepens its engagement with Alivus Lifesciences, the Rs 4.4 crore order underscores a broader shift—where pharma meets tech, and advisory excellence drives digital transformation.

Sources: Business Standard, UNI India, MoneyWorks4Me, HDFC Sky, Tribune India

Stay Ahead – Explore Now! Government Denies Rumors of RBI Replacing Paper Currency in June